Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
14.16
+0.87 (6.55%)
At close: Sep 26, 2025, 4:00 PM EDT
13.89
-0.27 (-1.91%)
After-hours: Sep 26, 2025, 6:58 PM EDT
Cogent Biosciences Employees
Cogent Biosciences had 205 employees as of December 31, 2024. The number of employees increased by 41 or 25.00% compared to the previous year.
Employees
205
Change (1Y)
41
Growth (1Y)
25.00%
Revenue / Employee
n/a
Profits / Employee
-$1,385,737
Market Cap
1.98B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 205 | 41 | 25.00% |
| Dec 31, 2023 | 164 | 26 | 18.84% |
| Dec 31, 2022 | 138 | 61 | 79.22% |
| Dec 31, 2021 | 77 | 62 | 413.33% |
| Dec 31, 2020 | 15 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
COGT News
- 24 days ago - Cogent Biosciences, Inc. (COGT) Presents At Citi's Biopharma Back To School Conference Transcript - Seeking Alpha
- 4 weeks ago - Cogent Biosciences Announces Participation in the Citi Biopharma Conference - GlobeNewsWire
- 7 weeks ago - Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Cogent Biosciences Announces Closing of Upsized Public Offering of Shares of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 2 months ago - Cogent: Positive Data In NonAdvSM Bodes Well For 2nd Half AdvSM Treatment Results - Seeking Alpha
- 2 months ago - Cogent Biosciences Announces Pricing of Upsized Public Offering of Shares of Common Stock - GlobeNewsWire
- 2 months ago - Cogent Biosciences Announces Proposed $150 Million Public Offering of Common Stock - GlobeNewsWire
- 2 months ago - Why Is Cogent Biosciences Stock Trading Higher On Monday? - Benzinga